Presented by Stephen P. Melek at the Executive Leadership Summit on March 24 - 26, 2015.
Medical costs for treating insured members with chronic medical and comorbid mental health/substance use disorder (MH/SUD) conditions can be 2-3 times as high as those beneficiaries who don‘t have the comorbid MH/SUD conditions. The additional health care costs incurred by people with behavioral comorbidities were estimated to be $293 billion in 2012 across commercially-insured, Medicaid, and Medicare beneficiaries in the United States. Most of the increased cost for those with comorbid MH/SUD conditions is attributed to medical services (not behavioral services), creating a large opportunity for savings on the medical side through integration of behavioral and medical services. Based on Milliman literature review on the results of effective IMBH programs, we calculate that 9-16% of this total additional spending may be saved through effective integration of care.